Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more ...

SLN ("Silence" or "the Company"), a global clinical stage biotechnology company committed to transforming people's lives by silencing diseases ...

DOHA: The Ministry of Public Health (MoPH) has launched Qatar's National Action Plan on Obesity, Diabetes, and Modifiable ...

SLN ("Silence" or "the Company"), a global clinical stage biotechnology company committed to transforming people's lives by silencing diseases through precision engineered ...

While statins can reduce LDL levels and ASCVD events, high Lp(a) poses an independent risk that will need attention, too.

This Phase 1 grant (1R43HL174270) is funded by the National Heart, Lung, and Blood Institute (NHLBI) for the further ...

THE Philippine Press Institute (PPI) has spearheaded a health reporting workshop to help local journalists gain a deeper ...

Thomas Smith, an analyst from Leerink Partners, reiterated the Buy rating on Tourmaline Bio (TRML – Research Report). The associated ...

Approximately 2.1 million Australians are diagnosed with high cholesterol.1 High cholesterol is a critical risk factor to atherosclerotic ...

Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death among U.S. adults. Despite declining rates of ASCVD mortality, significant disparities across multiple social and ...

On track to report topline data from Phase 2 TRANQUILITY trial in first half of 2025 – – Assembled Cardiovascular Scientific Advisory B ...

Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death among U.S. adults. Despite declining rates of ASCVD mortality, significant disparities across multiple social and ...